Get started
Author

Taku Nakagawa

Observed name: T. Nakagawa
Observed institution: Omagari Kousei Medical Center
ORCID: 0000-0003-1281-2412
Observed ORCID: 0000-0003-1281-2412
OpenAlex ID: A5044821698
A Large-Scale Prospective Concordance Study of Plasma- and Tissue-Based Next-Generation Targeted Sequencing for Advanced Non–Small Cell Lung Cancer (LC-SCRUM-Liquid)
2022 · Akira Sugimoto, Shingo Matsumoto, et al. · Clinical Cancer Research · 76
Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047)
2024 · Tetsuhiko Asao, Takehito Shukuya, et al. · Lung Cancer · 11
PDF
A phase II study of daily carboplatin plus irradiation followed by durvalumab therapy for older adults (≥75 years) with unresectable III non-small-cell lung cancer and performance status of 2: NEJ039A
2024 · A. Mouri, A. Kisohara, et al. · ESMO Open · 10
PDF
Prospective Multi-Institutional Observational Study of Retreatment with Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1/PD-L1 Plus Chemotherapy: NJLCG (North Japan Lung Cancer Group) Trial 1901
2025 · Shin Saito, Yosuke Kawashima, et al. · Cancers · 1
PDF
Data from A Large-Scale Prospective Concordance Study of Plasma- and Tissue-Based Next-Generation Targeted Sequencing for Advanced Non–Small Cell Lung Cancer (LC-SCRUM-Liquid)
2023 · Akira Sugimoto, Shingo Matsumoto, et al. · 1
Phase I and early phase II study of enhancing immune checkpoint inhibitor efficacy using a Mycobacterium tuberculosis extract combined with radiation therapy in non-small cell lung cancer patients: NEJ046A
2026 · Atsuto Mouri, Jun Sugisaka, et al. · Lung Cancer
Discrepancy between plasma cell-free DNA and tissue-based analysis for detection of gene amplifications in non–small cell lung cancer.
2026 · Haruka Nakatani, Hibiki Udagawa, et al. · Journal of Clinical Oncology
PDF
Supplementary Figures S1-S4 from A Large-Scale Prospective Concordance Study of Plasma- and Tissue-Based Next-Generation Targeted Sequencing for Advanced Non–Small Cell Lung Cancer (LC-SCRUM-Liquid)
2025 · Akira Sugimoto, Shingo Matsumoto, et al.
PDF
Supplementary Tables S1-S4 from A Large-Scale Prospective Concordance Study of Plasma- and Tissue-Based Next-Generation Targeted Sequencing for Advanced Non–Small Cell Lung Cancer (LC-SCRUM-Liquid)
2025 · Akira Sugimoto, Shingo Matsumoto, et al.
Data from A Large-Scale Prospective Concordance Study of Plasma- and Tissue-Based Next-Generation Targeted Sequencing for Advanced Non–Small Cell Lung Cancer (LC-SCRUM-Liquid)
2023 · Akira Sugimoto, Shingo Matsumoto, et al.
Supplementary Tables S1-S4 from A Large-Scale Prospective Concordance Study of Plasma- and Tissue-Based Next-Generation Targeted Sequencing for Advanced Non–Small Cell Lung Cancer (LC-SCRUM-Liquid)
2023 · Akira Sugimoto, Shingo Matsumoto, et al.
Supplementary Figures S1-S4 from A Large-Scale Prospective Concordance Study of Plasma- and Tissue-Based Next-Generation Targeted Sequencing for Advanced Non–Small Cell Lung Cancer (LC-SCRUM-Liquid)
2023 · Akira Sugimoto, Shingo Matsumoto, et al.
PDF
Supplementary Figure from A Large-Scale Prospective Concordance Study of Plasma- and Tissue-Based Next-Generation Targeted Sequencing for Advanced Non–Small Cell Lung Cancer (LC-SCRUM-Liquid)
2023 · Akira Sugimoto, Shingo Matsumoto, et al.
PDF
Supplementary Figure from A Large-Scale Prospective Concordance Study of Plasma- and Tissue-Based Next-Generation Targeted Sequencing for Advanced Non–Small Cell Lung Cancer (LC-SCRUM-Liquid)
2023 · Akira Sugimoto, Shingo Matsumoto, et al.
Supplementary Data from A Large-Scale Prospective Concordance Study of Plasma- and Tissue-Based Next-Generation Targeted Sequencing for Advanced Non–Small Cell Lung Cancer (LC-SCRUM-Liquid)
2023 · Akira Sugimoto, Shingo Matsumoto, et al.
Supplementary Data from A Large-Scale Prospective Concordance Study of Plasma- and Tissue-Based Next-Generation Targeted Sequencing for Advanced Non–Small Cell Lung Cancer (LC-SCRUM-Liquid)
2023 · Akira Sugimoto, Shingo Matsumoto, et al.
Works count: 16
Citation count: 99
H-index: 3
I10-index: 3
Year
Topic
Type